Company Quick10K Filing
DOCASA
10-K 2018-12-31 Filed 2019-04-17
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-27
10-Q 2018-03-31 Filed 2018-05-15
10-Q 2017-11-30 Filed 2018-01-19
10-K 2017-08-31 Filed 2017-12-18
10-Q 2017-05-31 Filed 2017-07-17
10-Q 2017-02-28 Filed 2017-04-14
10-Q 2016-11-30 Filed 2017-01-24
10-K 2016-07-31 Filed 2016-10-04
10-Q 2016-04-30 Filed 2016-06-14
10-Q 2016-01-31 Filed 2016-03-22
10-Q 2015-10-31 Filed 2015-12-14
10-K 2015-07-31 Filed 2015-10-20
10-Q 2015-04-30 Filed 2015-06-15
10-Q 2015-01-31 Filed 2015-03-17
8-K 2019-04-26
8-K 2018-12-04
8-K 2018-08-28
8-K 2018-08-20
8-K 2018-07-17
8-K 2018-02-23
8-K 2017-12-28

DOCASA Financials

DCSA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420
SWK Holdings (SWKH) 167,159 0% 9.7 6% 247,535 19,907 21,396 0 15,043 16,831 162,673
DOCASA (DCSA) 166,631 24% -117.8 -8% 22,047 6,626 6,454 1,527 -1,773 -1,408 165,842
Jamba (JMBA) 165,009 0% 68.1 -4% 36,654 46,912 78,265 0 -1,563 2,289 155,914
QNB (QNBC) 162,260 5.6 1% 1,245,863 1,126,878 0 0 11,939 25,390 141,473
Diverse Development Group (DDG) 161,311 -3,433.4 -24,302% 0 174 0 0 -43 -47 161,311
Gold Reserve (GDRZF) 161,165 -8.9 -15% 78,340 104,144 0 0 -11,575 -11,575 103,488
Blackstar Enterprise Group (BEGI) 156,000 -313.5 -13,158% 4 279 0 0 -498 -498 156,000
Invesco CurrencyShares British Pound Sterling Trust (FXB) 155,714 0% -5.1 -0% 155,390 51 484 0 -73 -73 369

Balance Sheet ($'000)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-11-302017-02-282017-05-312017-08-312017-11-302018-03-312018-06-302018-09-302018-12-31
Cash07000008620219493202923481,1052,540
Accounts Receivable0000699664785497527738782898600
Inventory222210388647109120139155392
PP&E1,2441,5421,8322,2942,6652,0872,6003,3966,667
Assets01,8942,1752,7302,4865,4856,0219,15911,06522,047
Accounts Payable23011428367389708501,5891,1891,5791,1282,009
Long-Term Debt292411457373113022822461,752
Liabilities351,3841,4001,7912,0243,2503,4034,8904,4856,626
Stockholders' Equity-4-1-10-27-32-36-355107759394622,235-2,218-1,400-246-3,114
Income Statement ($'000)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-11-302017-02-282017-05-312017-08-312017-11-302018-03-312018-06-302018-09-302018-12-31
Revenue0000209179211,1631,1801,5231,8242,0912,539
Cost of Revenue0105737169031,4411,1761,1471,7632,017
Gross Profit010343205260-261347677328522
R&D
SG&A0361132-16
Tax00000010000000
Net Income-5-7-8-17-5-42-59-214-131-1,006-8610-951-832
Cash Flow ($'000)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-11-302017-02-282017-05-312017-08-312017-11-302018-03-312018-06-302018-09-302018-12-31
Cash Operating-8-11-16-4-1087-27462-606793149-707-1,238
Cash Investing00000-167-215-362-87-335-151-121-1,211
Cash Financing1551641-176605292593-349-469283,206